In vivo evidence of a positive role of KS‐WNK1 on NCC activity was recently provided with the description of mutations in the region encoding the acidic domain of WNK1 that cause a mild FHHt phenotype in humans (hyperkalemic metabolic acidosis) (Louis‐Dit‐Picard et al, 2020). Here, WNK1 is linked to metabolic acidosis.